Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
bluebird bio Stock Price (Quote) NASDAQ:BLUE
$8.73 ( 2.46% ) Friday, 14th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $8.12 | $11.70 | Friday, 14th Jan 2022 BLUE stock ended at $8.73. This is 2.46% more than the trading day before Thursday, 13th Jan 2022. During the day the stock fluctuated 7.09% from a day low at $8.18 to a day high of $8.76. |
| 90 days | $8.12 | $25.39 | |
| 52 weeks | $8.12 | $52.80 |
Historical bluebird bio prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-14 | $8.57 | $8.76 | $8.18 | $8.73 | 2 062 269 |
| 2022-01-13 | $8.87 | $9.08 | $8.50 | $8.52 | 1 753 878 |
| 2022-01-12 | $9.54 | $9.57 | $8.90 | $8.92 | 1 318 219 |
| 2022-01-11 | $9.47 | $9.85 | $9.46 | $9.57 | 1 215 038 |
| 2022-01-10 | $9.36 | $9.43 | $8.96 | $9.41 | 1 835 121 |
| 2022-01-07 | $9.77 | $10.07 | $9.53 | $9.55 | 918 970 |
| 2022-01-06 | $9.94 | $10.15 | $9.69 | $9.80 | 1 390 300 |
| 2022-01-05 | $10.24 | $10.51 | $9.90 | $9.91 | 1 285 421 |
| 2022-01-04 | $10.58 | $10.74 | $10.12 | $10.28 | 986 808 |
| 2022-01-03 | $10.09 | $10.68 | $10.09 | $10.60 | 1 234 823 |
| 2021-12-31 | $10.43 | $10.64 | $9.91 | $9.99 | 1 345 815 |
| 2021-12-30 | $10.42 | $10.84 | $10.31 | $10.35 | 1 533 650 |
| 2021-12-29 | $10.74 | $10.82 | $10.26 | $10.41 | 857 922 |
| 2021-12-28 | $10.93 | $11.58 | $10.77 | $10.77 | 2 489 631 |
| 2021-12-27 | $11.38 | $11.43 | $10.77 | $10.94 | 4 161 581 |
| 2021-12-23 | $11.21 | $11.70 | $11.07 | $11.40 | 1 852 042 |
| 2021-12-22 | $11.49 | $11.55 | $11.04 | $11.12 | 2 709 667 |
| 2021-12-21 | $10.50 | $11.59 | $10.37 | $11.58 | 2 890 124 |
| 2021-12-20 | $8.45 | $10.76 | $8.12 | $10.71 | 9 153 305 |
| 2021-12-17 | $9.14 | $10.69 | $9.11 | $10.62 | 8 873 007 |
| 2021-12-16 | $9.56 | $9.87 | $9.30 | $9.37 | 1 338 206 |
| 2021-12-15 | $9.22 | $9.51 | $8.83 | $9.51 | 2 239 000 |
| 2021-12-14 | $9.40 | $9.74 | $9.14 | $9.16 | 2 221 988 |
| 2021-12-13 | $9.48 | $9.69 | $8.98 | $9.51 | 4 405 942 |
| 2021-12-10 | $9.33 | $9.47 | $8.90 | $8.96 | 1 280 183 |
| 2021-12-09 | $9.89 | $9.96 | $9.37 | $9.38 | 1 665 072 |
| 2021-12-08 | $10.04 | $10.06 | $9.70 | $10.00 | 1 600 482 |
| 2021-12-07 | $10.07 | $10.35 | $9.85 | $9.95 | 1 617 130 |
| 2021-12-06 | $9.90 | $10.19 | $9.79 | $10.01 | 1 360 100 |
| 2021-12-03 | $10.63 | $10.65 | $9.88 | $9.95 | 1 216 333 |
| 2021-12-02 | $9.97 | $10.68 | $9.84 | $10.63 | 1 501 360 |
| 2021-12-01 | $10.22 | $10.77 | $10.05 | $10.05 | 1 464 514 |
| 2021-11-30 | $10.16 | $10.46 | $9.89 | $10.11 | 1 531 287 |
| 2021-11-29 | $10.76 | $10.90 | $10.30 | $10.33 | 1 305 921 |
| 2021-11-26 | $10.60 | $10.89 | $10.35 | $10.50 | 1 816 606 |
| 2021-11-24 | $10.59 | $10.92 | $10.46 | $10.76 | 4 602 460 |
| 2021-11-23 | $10.39 | $10.75 | $10.21 | $10.73 | 1 691 563 |
| 2021-11-22 | $11.31 | $11.36 | $10.40 | $10.54 | 2 179 677 |
| 2021-11-19 | $10.80 | $11.05 | $10.54 | $10.70 | 1 418 962 |
| 2021-11-18 | $11.34 | $11.34 | $10.76 | $10.91 | 1 637 524 |
| 2021-11-17 | $11.55 | $11.60 | $11.09 | $11.31 | 1 163 901 |
| 2021-11-16 | $11.48 | $11.65 | $11.23 | $11.58 | 1 705 576 |
| 2021-11-15 | $11.80 | $11.81 | $11.12 | $11.48 | 1 314 685 |
| 2021-11-12 | $11.50 | $11.76 | $11.13 | $11.68 | 1 667 090 |
| 2021-11-11 | $11.28 | $12.12 | $11.25 | $11.68 | 2 209 858 |
| 2021-11-10 | $10.73 | $11.74 | $10.60 | $11.31 | 4 420 338 |
| 2021-11-09 | $10.70 | $10.88 | $10.35 | $10.88 | 3 746 705 |
| 2021-11-08 | $12.62 | $12.62 | $10.59 | $10.70 | 8 177 711 |
| 2021-11-05 | $17.74 | $17.85 | $12.90 | $13.14 | 6 123 474 |
| 2021-11-04 | $24.95 | $25.39 | $23.98 | $25.19 | 830 522 |
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases. Its product candidates include Lenti-D, which is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare, hereditary neurological disorder; and LentiGlobin that is in phase I/II clinical studies for the treatment of beta-thalassemia major and severe sickle cell di... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
